Society Logo
ME/CFS Australia Ltd
Please Click Here To Donate ME/CFS Australia (SA) Inc
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 698

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 277KB)
Why become a member?

Panax ginseng compared to Amitriptyline and placebo for Fibromyalgia

Thursday 25 April 2013

 

From ProHealth:

 

Panax ginseng root extractPanax Ginseng Compared to Amitriptyline and Placebo for Fibromyalgia

ProHealth.com • April 20, 2013

Editor's Comment: Panax ginseng is a variety of ginseng commonly used in herbal medicine. Forms of Panax ginseng include white ginseng and red ginseng. The active components in Panax Ginseng support the production of an adrenal hormone, to promote motivation and vitality.

Note: You may read the full text of this article in English free HERE.

Effects of Panax ginseng extract in patients with fibromyalgia: a 12-week, randomized, double-blind, placebo-controlled trial.

By Alessandra S. Braz, et al.

Abstract:

The purpose of the study was to evaluate the efficacy of an extract of Panax ginseng in patients with fibromyalgia.

A randomized, double-blind, controlled clinical trial was carried out over 12 weeks to compare the effects of P. ginseng (100 mg/d) with amitriptyline (25 mg/d) and placebo in 38 patients with fibromyalgia:

  • 13 in Group I (amitriptyline),

  • 13 in Group II (placebo), and

  • 12 in Group III (P. ginseng).

Ratings on the Visual Analogue Scale (VAS) revealed a reduction in pain in the P. ginseng group (p < .0001), an improvement in fatigue (p < .0001) and an improvement in sleep (p < .001), with respect to baseline characteristics, but there were no differences between the three groups.

With respect to anxiety, improvements occurred in the P. ginseng group compared to baseline (p < .0001); however, amitriptyline treatment resulted in significantly greater improvements (p < .05). P. ginseng reduced the number of tender points and improved patients' quality of life (using the Fibromyalgia Impact Questionnaire - FIQ); however, there were no differences between groups.

The beneficial effects experienced by patients for all parameters suggest a need for further studies to be performed on the tolerability and efficacy of this phytotherapic as a complementary therapy for fibromyalgia.

Source: Revista Brasileira de Psiquiatria, March 2013. By Alessandra S. Braz, Liana Clébia S. Morais, Ana Patríca Paula, Margareth F. F. M. DinizI Reinaldo N. Almeida. Laboratory of Pharmaceutical Technology, Universidade Federal da Paraíba, Brazil.

 

The above originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus
Previous Previous Page